Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.908,46
1,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Paratek Pharmaceuticals Inc (PRTK) Paratek Pharmaceuticals Inc (PRTK) Notizie

Paratek Pharmaceuticals Inc

PRTK
2,23
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/10/202314:00GLOBEParatek Pharmaceuticals to Present NUZYRA Data at IDWeek..
02/10/202313:33EDGAR2Form 15-12G - Securities registration termination [Section..
26/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202319:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202316:59EDGAR2Form SC 13E3/A - Going private transaction by certain..
21/9/202316:42EDGAR2Form POS AM - Post-Effective amendments for registration..
21/9/202316:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
21/9/202315:10EDGAR2Form 25-NSE - Notification filed by national security..
21/9/202315:07EDGAR2Form 8-K - Current report
21/9/202314:58GLOBEGurnet Point Capital and Novo Holdings A/S Complete..
18/9/202323:23EDGAR2Form SC 13E3/A - Going private transaction by certain..
18/9/202318:49EDGAR2Form 8-K - Current report
12/9/202323:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202322:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202322:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202315:14EDGAR2Form SC 13E3/A - Going private transaction by certain..
11/9/202313:46EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202313:42EDGAR2Form 8-K - Current report
07/9/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/8/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/8/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/8/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/8/202322:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/8/202322:50EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/8/202323:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/8/202302:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202320:37BWInvestor Alert: Abbott Cooper PLLC Announces Investigation..
03/8/202314:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:00GLOBEParatek Pharmaceuticals Announces Second Quarter 2023..
02/8/202323:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/8/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/8/202323:03EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
28/7/202320:01EDGAR2Form SC 13E3/A - Going private transaction by certain..
28/7/202318:55EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
11/7/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
Apertura: Min: Max:
Chiusura: 2,23

La tua Cronologia

NASDAQ
PRTK
Paratek Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network